NasdaqCM - Delayed Quote USD

Sonnet BioTherapeutics Holdings, Inc. (SONN)

1.8450 +0.0550 (+3.07%)
At close: April 24 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
129.1760
147.8050
349.9430
483.6260
--
Operating Expense
14,588.2700
18,940.4220
30,019.3020
25,571.0620
17,411.2770
Operating Income
-14,459.0940
-18,792.6170
-29,669.3590
-25,087.4360
-17,411.2770
Net Non Operating Interest Income Expense
--
--
--
0.0150
20.6770
Other Income Expense
0.0330
-40.0770
-52.4820
103.4600
-6,874.5150
Pretax Income
-14,459.0610
-18,832.6940
-29,721.8410
-24,983.9610
-24,265.1150
Net Income Common Stockholders
-14,459.0610
-18,832.6940
-29,721.8410
-24,983.9610
-65,604.0490
Diluted NI Available to Com Stockholders
-14,459.0610
-18,832.6940
-29,721.8410
-24,983.9610
-65,604.0490
Basic EPS
-0.83
-18.14
-150.52
-313.50
-2.14k
Diluted EPS
-0.83
-18.14
-150.52
-313.50
-2.14k
Basic Average Shares
1,909.0080
1,038.1880
197.4620
79.6990
30.5850
Diluted Average Shares
1,909.0080
1,038.1880
197.4620
79.6990
30.5850
Total Operating Income as Reported
-14,459.0940
-18,792.6170
-29,669.3590
-25,087.4360
-24,237.7720
Total Expenses
14,588.2700
18,940.4220
30,019.3020
25,571.0620
17,411.2770
Net Income from Continuing & Discontinued Operation
-14,459.0610
-18,832.6940
-29,721.8410
-24,983.9610
-24,265.1150
Normalized Income
-14,459.0940
-18,792.6170
-29,669.3590
-24,961.9200
-17,390.6000
Interest Income
--
--
--
0.0150
20.6770
Net Interest Income
--
--
--
0.0150
20.6770
EBIT
-14,459.0940
-18,792.6170
-29,669.3590
-25,087.4360
-17,411.2770
EBITDA
-14,381.8040
-18,716.8670
-29,576.1020
-24,992.2740
-17,352.9640
Reconciled Depreciation
77.2900
75.7500
93.2570
95.1620
58.3130
Net Income from Continuing Operation Net Minority Interest
-14,459.0610
-18,832.6940
-29,721.8410
-24,983.9610
-24,265.1150
Total Unusual Items Excluding Goodwill
0.0330
-40.0770
-52.4820
-22.0410
-6,874.5150
Total Unusual Items
0.0330
-40.0770
-52.4820
-22.0410
-6,874.5150
Normalized EBITDA
-14,381.8370
-18,676.7900
-29,523.6200
-24,970.2330
-10,478.4490
9/30/2020 - 10/31/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HOTH Hoth Therapeutics, Inc.
1.1700
-1.68%
 
NRBO NeuroBo Pharmaceuticals, Inc.
3.1000
+2.65%
 
ADTX Aditxt, Inc.
2.3700
+4.41%
 
DRUG Bright Minds Biosciences Inc.
1.0900
-2.68%
 
VCNX Vaccinex, Inc.
5.01
+1.32%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.6321
-5.30%
 
XBIO Xenetic Biosciences, Inc.
3.8400
-0.26%
 
KPRX Kiora Pharmaceuticals, Inc.
0.5058
-12.72%
 
VRPX Virpax Pharmaceuticals, Inc.
3.1700
+0.63%
 
TENX Tenax Therapeutics, Inc.
3.5600
+0.85%